Daily Archives: February 4, 2021 | LinksMedicus Free Medical News & Perspectives

Policy Statement: Antibiotic Stewardship in Pediatrics

4 Feb, 2021 | 01:21h | UTC

Antibiotic Stewardship in Pediatrics – Pediatrics

Commentary: Guidance Provided for Antibiotic Stewardship in Pediatrics

Randomized trial: Safety and efficacy of long-term mild hypothermia for severe traumatic brain injury with refractory intracranial hypertension

4 Feb, 2021 | 01:18h | UTC

Safety and efficacy of long-term mild hypothermia for severe traumatic brain injury with refractory intracranial hypertension (LTH-1): A multicenter randomized controlled trial – EClinicalMedicine

Commentary on Twitter

Does induced hypothermia/targetted temp management improve outcomes in patients with traumatic brain injury?

Maybe or maybe not

But this trial slow to cool, not very cool, underpowered and mod rate of dropout

Prob does not answer questionhttps://t.co/UGRFmUVNV0 pic.twitter.com/c0iDqj2l2e

— Graham Nichol (@grahamnichol) January 29, 2021

Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys

4 Feb, 2021 | 01:20h | UTC

Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys – The Lancet Child & Adolescent Health (link to abstract – $ for full-text)

Commentary on Twitter

NEW—Global Youth Tobacco Surveys data from 13–15-year-olds in 140 countries, suggests 40% of countries show no progress in reducing cigarette smoking in adolescents over the past 20 years. Read more findings from the @LancetChildAdol study: https://t.co/qlHzvHHdOD

— The Lancet (@TheLancet) February 3, 2021

State of the Art Review: Uveitis for the non-ophthalmologist

4 Feb, 2021 | 01:22h | UTC

Uveitis for the non-ophthalmologist – The BMJ (free for a limited period)

Consensus statement for perioperative care in lumbar spinal fusion: Enhanced Recovery After Surgery (ERAS®) Society recommendations

4 Feb, 2021 | 01:15h | UTC

Consensus statement for perioperative care in lumbar spinal fusion: Enhanced Recovery After Surgery (ERAS®) Society recommendations – The Spine Journal

German 2021 guideline update on acute therapy and management of anaphylaxis

4 Feb, 2021 | 01:17h | UTC

Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update – Allergo Journal International

Systematic review: Telerehabilitation for chronic respiratory disease

4 Feb, 2021 | 01:08h | UTC

Telerehabilitation for chronic respiratory disease – Cochrane Library

Summary: How does using technology to deliver pulmonary rehabilitation (PR) compare to centre-based PR, or no PR in people with chronic lung disease? – Cochrane Library

Observational study suggests a conservative approach to inpatient hypertension may be safer

4 Feb, 2021 | 01:14h | UTC

Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions – JAMA Internal Medicine (link to abstract – $ for full-text)

Commentary on Twitter

#Hypertension is common in the inpatient setting, but antihypertensive intensification is not. Intensification of therapy without signs of end-organ damage is associated with worse outcomes https://t.co/y1MdZNfi9P

— JAMA Internal Medicine (@JAMAInternalMed) December 29, 2020

WHO: Consecutive drop in new COVID-19 cases ‘encouraging news’

4 Feb, 2021 | 01:37h | UTC

Consecutive drop in new COVID-19 cases ‘encouraging news’: WHO – UN News

UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus

4 Feb, 2021 | 01:32h | UTC

UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus – Biobank

Commentary: Covid: Antibodies last at least six months in most – BBC

RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19

4 Feb, 2021 | 01:39h | UTC

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet

Invited Commentary: Azithromycin, RECOVERY, and the power of large, simple trials – The Lancet

Study shows the viral load of index cases is a leading driver of SARS-CoV-2 transmission

4 Feb, 2021 | 01:35h | UTC

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study – The Lancet Infectious Diseases

Commentary: Understanding the drivers of transmission of SARS-CoV-2 – The Lancet Infectious Diseases

Racing the virus: Why tweaking vaccines to fight variants won’t be simple

4 Feb, 2021 | 01:28h | UTC

Racing the virus: Why tweaking vaccines to fight variants won’t be simple – Reuters

Video (3 min): Sinovac and Sinopharm – what do we know about the Chinese vaccines?

4 Feb, 2021 | 01:31h | UTC

Sinovac and Sinopharm – what do we know about the Chinese vaccines? – BBC

[Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19

4 Feb, 2021 | 01:26h | UTC

More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis – medRxiv

Commentary: 80% of COVID-19 Patients May Have Lingering Symptoms, Signs — More than 50 effects persisted after acute infection, meta-analysis shows – MedPage Today (free registration required)

Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week

4 Feb, 2021 | 01:27h | UTC

Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week – Journal of the American College of Cardiology

Commentary on Twitter

How common is COVID-19-induced myocarditis as evaluated by histologic examination of autopsy or EMB specimens? Short answer: its pretty uncommon. See our State of the Art Review in JACC this week. https://t.co/SlzQ4ICwTW

— Aloke Finn (@AlokeFinn) January 19, 2021